510(k) Report

510(k) · Cleared

Cleared

Igx Plex Rheumatoid Arthritis (RA) Assay and Sqidworks Diagnostics Platform

K083080510(k) TraditionalCleared Oct 29, 2009378-day reviewClass II21 CFR 866.5775

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sqi Diagnostics Systems · DHR System, Test, Rheumatoid Factor

Cleared on Oct 29, 2009 as substantially equivalent to K983084 (Inova Diagnostics, Inc., 1998) and 3 other predicates after a 378-day review. Its family tree reaches back 2 generations to 1992.

Decided
Oct 29, 2009
Review
378 days
Class
Class II
Product code
DHR
Recalls
None
Predicates
4

Its longest line of descent runs back 2 generations to K922830 (1992). 18 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2005: 1 other ancestor1998: 3 other ancestors1997: 2 other ancestors2001: 1 other ancestor2000: 1 other ancestor1999: 1 other ancestor1995: 4 other ancestors1993: 1 other ancestor1992: 2 other ancestorsK922830 · Quanta Lite SS-a Elisa · Inova Diagnostics, Inc. · 1992K041658 · Bioplex 200 Ana Screen on the Bioplex 2200 Multi-Analyte Detection System, Model Bioplex 2200 · Bio-Rad Laboratories, Inc. · 2004 · recalled19901995200020052010
Other ancestors, by generation 1 generation back: 3 other ancestors2 generations back: 13 other ancestors K041658 · Bioplex 200 Ana Screen on the Bioplex 2200 Multi-Analyte Detection System, Model Bioplex 2200 · Bio-Rad Laboratories, Inc. · 2004 · recalledK922830 · Quanta Lite SS-a Elisa · Inova Diagnostics, Inc. · 19920
  1. Root · 2 generations backK922830 Quanta Lite SS-a ElisaInova Diagnostics, Inc. · 1992
  2. 1 generation backK041658 Bioplex 200 Ana Screen on the Bioplex 2200 Multi-Analyte Detection…Bio-Rad Laboratories, Inc. · 2004 · Recalled
  3. This deviceK083080 Igx Plex Rheumatoid Arthritis (RA) Assay and Sqidworks Diagnostics…Sqi Diagnostics Systems · 2009
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K922830Quanta Lite SS-a ElisaInova Diagnostics, Inc.1992—
−1K041658Bioplex 200 Ana Screen on the Bioplex 2200 Multi-Analyte Detection System…Bio-Rad Laboratories, Inc.20041
0 (this device)K083080Igx Plex Rheumatoid Arthritis (RA) Assay and Sqidworks Diagnostics PlatformSqi Diagnostics Systems2009—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199220
199310
199540
199720
199830
199910
200010
200110
200510
FIG. 1 — Lineage of K083080, 1992–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DHR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K983084Quanta Lite RF Iga Elisa
Summary page 5
…stic IgX PLEX RF IgA QUANTA LiteTM RIF IgA K983084 Intended Use As aid in diagnosis of rheumatoid Same…
Inova Diagnostics, Inc.1998—
*K971614Quanta Lite RF Igm
Summary page 5
…teristic IgX PLEX RV IgM QUANTA Lite RFIgM K971614 Intended Use As aid in diagnosis of rheumatoid Same…
Inova Diagnostics, Inc.1997—
*K052264Quanta Lite CCP3 Igg Elisa
Summary page 5
…istic IgX PLEX Anti-CCP IgG QUANTA Lite CCP3 IgG K052264 Intended Use As aid in diagnosis of rheumatoid Same…
Inova Diagnostics, Inc.2005—
*K041658Bioplex 200 Ana Screen on the Bioplex 2200 Multi-Analyte Detection System, Model Bioplex…
Summary page 6
…Diagnostic Platform Detection System K041658 Multi-analyte Yes Same Multiplexing Method…
Bio-Rad Laboratories, Inc.20041

Also cleared against K983084: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 3 companies; a new generation was cleared every 12.3 years on median.
  • 3 of the 18 ancestors have a recall of any class.
  • 1 other device also cites its predicate K983084.

How does its category compare?

All DHR devices

DHR System, Test, Rheumatoid Factor: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · DHR

1in 2020

2007: 12009: 12010: 12011: 12015: 12016: 12017: 12018: 12019: 12020: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DHR

Too few DHR 510(k)s in any year since 2007 to give a median.

Recalls per year · DHR

1in 2019

2010: 12011: 32012: 22018: 22019: 1
2007high 3 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DHR

2in 2025

2010: 192011: 4002012: 912018: 12024: 32025: 2
2007high 400 (2011) · low 0 (2007)2025

MAUDE reports naming product code DHR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20091—00
20101—119
20111—3400
20120—291
20130—00
20140—00
20151—00
20161—00
20171—00
20181—21
20191—10
20201—00
20210—00
20220—00
20230—00
20240—03
20250—02
20260—0—

What is it indicated for?

The IgX PLEXTM Rheumatoid Arthritis Qualitative Assay and SQiDworksTM Diagnostics Platform is an in vitro diagnostic test system for the qualitative detection of the IgA and IgM classes of Rheumatoid Factors, and the IgG class of anti-cyclic citrullinated peptide antibodies (CCP-proprietary third generation equivalent formulation) in human serum specimens.

The IgX PLEXTM Rheumatoid Arthritis Qualitative Assay is intended for use in clinical laboratories as an aid in the diagnosis of Rheumatoid Arthritis in conjunction with other laboratory and clinical findings, and requires the SQiDworksTM Diagnostics Platform.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K083080: Igx Plex Rheumatoid Arthritis (RA) Assay and Sqidworks Diagnostics Platform.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K083080

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026